Hikma Pharmaceuticals PLC
HIK
Pozycja w akcjach
#25456
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Cena akcji
$22.61
Kapitalizacja rynkowa
$46.82M
Zmiana (1 dzień)
0.48%
Zmiana (1 rok)
-52.37%
Kraj
GB
Handel Hikma Pharmaceuticals PLC (HIK)
Kategoria
Healthcare
Kapitalizacja rynkowa Hikma Pharmaceuticals PLC(HIK)
Kapitalizacja rynkowa: $46.82M
Na dzień October 2026 spółka Hikma Pharmaceuticals PLC ma kapitalizację rynkową wynoszącą $46.82M. Według naszych danych, czyni to Hikma Pharmaceuticals PLC 25456th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Hikma Pharmaceuticals PLC od 2011 do 2026
HIK w porównaniu do 5 najpopularniejszych stocks
